I addressed how we should shift the conversation past demands for access and inclusion toward a critical understanding of the racial justice implications of new biotechnologies, based on my work on race-specific biomedical research, drugs, ancestry testing, and DNA collection, as well as my experience as a member of the Generations Ahead Advisory Board.  The debate among black health advocates over BiDil, a heart failure therapy approved for African Americans, illustrates the tension between group demands to be included in cutting-edge personalized medicine and recognition of the dangers of genetic concepts of race and explanations for health disparities.  A similar tension between inclusion in technological advances and a more critical analysis of the relationship between genetic technologies and racial justice exists in the embrace of some African Americans of genetic testing to trace ties to Africa and DNA collection to assist in exonerating innocent prisoners.  At the same time, the work of Generations Ahead with movement leaders also revealed the need to explain how genetic technologies are relevant to their urgent racial justice concerns.